Logo

miRNA

Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis

On the heels of its Genome Explorations acquisition, the company wants to create a biomarker panel to differentiate mild traumatic brain injury from PTSD.

Diagnostics Developer Early is Good Raises $4M in Seed Funding

The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.

MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations

The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.

Cardior Pharmaceuticals MicroRNA PCR Kit Receives CE Marking

The kit measures circulating levels of miR-132 in patients receiving Cardior's experimental inhibitor of that microRNA to help treat heart failure patients.

Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
Premium

The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.

Feb 2, 2022

Spain's ICN2 Awarded €161K to Develop Point-of-Care Test for Breast Cancer Diagnosis
Premium

Oct 13, 2021

MiRxes to Expand miRNA Assay Technology to Multiple Cancer Types, Other Disease Areas
Premium

Aug 5, 2021

Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test
Premium

Jul 30, 2021

Lithuanian Team Developing Droplet-Based Single-Cell Small RNA Sequencing Approach
Premium

Apr 23, 2021

COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood

Nov 4, 2020

Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia
Premium

Oct 22, 2020

Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19
Premium

Sep 15, 2020

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

Jul 9, 2020

Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories

May 11, 2020

Genetic Ancestry Linked to Differences in Molecular Features of Cancers

Apr 6, 2020

MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
Premium

Mar 5, 2020

Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer

Dec 18, 2019

ALS Genomic Analysis Highlights Potential MicroRNA Contributor

Nov 21, 2019

DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research

Oct 10, 2019

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

Sep 30, 2019

Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans

Sep 19, 2019

Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia
Premium

Sep 16, 2019

Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA

Aug 29, 2019

Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform

Aug 13, 2019

Interpace Diagnostics Q2 Revenues Climb 14 Percent

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.